# Josep M. Llovet

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/josep-m-llovet/

## Facts

| Field | Value |
| --- | --- |
| Citations | 157,199 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 154 |
| i10-index | 346 |
| Last Known Institution | Institució Catalana de Recerca i Estudis Avançats |
| OpenAlex ID | https://openalex.org/A5052975894 |
| ORCID iD | https://orcid.org/0000-0003-0547-2667 |
| Works | 798 |

## Researcher papers

- [Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis](https://scholariq.org/papers/predicting-survival-after-liver-transplantation-in-patients-with-hepatocellular/)
- [Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/ramucirumab-after-sorafenib-in-patients-with-advanced-hepatocellular-carcinoma/)
- [β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma](https://scholariq.org/papers/catenin-activation-promotes-immune-escape-and-resistance-to-anti-pd-1-therapy-in/)
- [Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial](https://scholariq.org/papers/lenvatinib-plus-pembrolizumab-versus-lenvatinib-plus-placebo-for-advanced/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

## Researcher university

- [Institució Catalana de Recerca i Estudis Avançats](https://scholariq.org/institutions/institucio-catalana-de-recerca-i-estudis-avancats/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.